Business Jul 25, 2014

GSK corruption allegations spread to Syria

GlaxoSmithKline faces new allegations of corruption, this time in Syria, where the drugmaker and its distributor have been accused of paying bribes to secure business, according to a whistleblower's email reviewed by Reuters. Britain's biggest drugmaker said Thursday it was investigating the latest claims dating ...